Development of calorie restriction mimetics as therapeutics for obesity, diabetes, inflammatory and neurodegenerative diseases

Takuya Chiba, Tomoshi Tsuchiya, Toshimitsu Komatsu, Ryoichi Mori, Hiroko Hayashi, Isao Shimokawa

研究成果: Article

13 引用 (Scopus)

抄録

Calorie restriction (CR) is the most robust intervention that decreases morbidity and mortality, and thereby increases the lifespan of many organisms. Although the signaling pathways involved in the beneficial effects of CR are not yet fully understood. Several candidate pathways and key molecules have been identified. The effects of CR are highly conserved from lower organisms such as yeast to higher mammals such as rodents and monkeys. Recent studies have also demonstrated beneficial effects of CR in humans, although we need much longer studies to evaluate whether CR also increases the lifespan of humans. In reality, it is difficult for us to conduct CR interventions in humans because the subjects must be kept in a state of hunger and the duration of this state needed to achieve a clinically meaningful effect is still unknown. Thus, research in this field is focusing on the development of molecules that mimic the beneficial effects of CR without reducing food intake. Some of these candidate molecules include plant-derived functional chemicals (phytochemicals), synthetic small molecules, and endocrine molecules such as adipokines. Several studies have already shown that this research field may yield novel drugs for the treatment of age-related diseases such as diabetes. In this article, we describe the target pathways, candidate molecules, and strategies to develop CR mimetics.

元の言語English
ページ(範囲)562-567
ページ数6
ジャーナルCurrent Genomics
11
発行部数8
DOI
出版物ステータスPublished - 2010
外部発表Yes

Fingerprint

Neurodegenerative Diseases
Obesity
Phytochemicals
Adipokines
Hunger
Research
Haplorhini
Mammals
Rodentia
Therapeutics
Eating
Yeasts
Morbidity
Mortality
Pharmaceutical Preparations

ASJC Scopus subject areas

  • Genetics
  • Genetics(clinical)

これを引用

Development of calorie restriction mimetics as therapeutics for obesity, diabetes, inflammatory and neurodegenerative diseases. / Chiba, Takuya; Tsuchiya, Tomoshi; Komatsu, Toshimitsu; Mori, Ryoichi; Hayashi, Hiroko; Shimokawa, Isao.

:: Current Genomics, 巻 11, 番号 8, 2010, p. 562-567.

研究成果: Article

Chiba, Takuya ; Tsuchiya, Tomoshi ; Komatsu, Toshimitsu ; Mori, Ryoichi ; Hayashi, Hiroko ; Shimokawa, Isao. / Development of calorie restriction mimetics as therapeutics for obesity, diabetes, inflammatory and neurodegenerative diseases. :: Current Genomics. 2010 ; 巻 11, 番号 8. pp. 562-567.
@article{6da3ab92ae7b45e7a00029455965ca34,
title = "Development of calorie restriction mimetics as therapeutics for obesity, diabetes, inflammatory and neurodegenerative diseases",
abstract = "Calorie restriction (CR) is the most robust intervention that decreases morbidity and mortality, and thereby increases the lifespan of many organisms. Although the signaling pathways involved in the beneficial effects of CR are not yet fully understood. Several candidate pathways and key molecules have been identified. The effects of CR are highly conserved from lower organisms such as yeast to higher mammals such as rodents and monkeys. Recent studies have also demonstrated beneficial effects of CR in humans, although we need much longer studies to evaluate whether CR also increases the lifespan of humans. In reality, it is difficult for us to conduct CR interventions in humans because the subjects must be kept in a state of hunger and the duration of this state needed to achieve a clinically meaningful effect is still unknown. Thus, research in this field is focusing on the development of molecules that mimic the beneficial effects of CR without reducing food intake. Some of these candidate molecules include plant-derived functional chemicals (phytochemicals), synthetic small molecules, and endocrine molecules such as adipokines. Several studies have already shown that this research field may yield novel drugs for the treatment of age-related diseases such as diabetes. In this article, we describe the target pathways, candidate molecules, and strategies to develop CR mimetics.",
keywords = "Biosensing, Calorie restriction, Cancer, Drug discovery, Metabolism, Neurodegeneration",
author = "Takuya Chiba and Tomoshi Tsuchiya and Toshimitsu Komatsu and Ryoichi Mori and Hiroko Hayashi and Isao Shimokawa",
year = "2010",
doi = "10.2174/138920210793360934",
language = "English",
volume = "11",
pages = "562--567",
journal = "Current Genomics",
issn = "1389-2029",
publisher = "Bentham Science Publishers B.V.",
number = "8",

}

TY - JOUR

T1 - Development of calorie restriction mimetics as therapeutics for obesity, diabetes, inflammatory and neurodegenerative diseases

AU - Chiba, Takuya

AU - Tsuchiya, Tomoshi

AU - Komatsu, Toshimitsu

AU - Mori, Ryoichi

AU - Hayashi, Hiroko

AU - Shimokawa, Isao

PY - 2010

Y1 - 2010

N2 - Calorie restriction (CR) is the most robust intervention that decreases morbidity and mortality, and thereby increases the lifespan of many organisms. Although the signaling pathways involved in the beneficial effects of CR are not yet fully understood. Several candidate pathways and key molecules have been identified. The effects of CR are highly conserved from lower organisms such as yeast to higher mammals such as rodents and monkeys. Recent studies have also demonstrated beneficial effects of CR in humans, although we need much longer studies to evaluate whether CR also increases the lifespan of humans. In reality, it is difficult for us to conduct CR interventions in humans because the subjects must be kept in a state of hunger and the duration of this state needed to achieve a clinically meaningful effect is still unknown. Thus, research in this field is focusing on the development of molecules that mimic the beneficial effects of CR without reducing food intake. Some of these candidate molecules include plant-derived functional chemicals (phytochemicals), synthetic small molecules, and endocrine molecules such as adipokines. Several studies have already shown that this research field may yield novel drugs for the treatment of age-related diseases such as diabetes. In this article, we describe the target pathways, candidate molecules, and strategies to develop CR mimetics.

AB - Calorie restriction (CR) is the most robust intervention that decreases morbidity and mortality, and thereby increases the lifespan of many organisms. Although the signaling pathways involved in the beneficial effects of CR are not yet fully understood. Several candidate pathways and key molecules have been identified. The effects of CR are highly conserved from lower organisms such as yeast to higher mammals such as rodents and monkeys. Recent studies have also demonstrated beneficial effects of CR in humans, although we need much longer studies to evaluate whether CR also increases the lifespan of humans. In reality, it is difficult for us to conduct CR interventions in humans because the subjects must be kept in a state of hunger and the duration of this state needed to achieve a clinically meaningful effect is still unknown. Thus, research in this field is focusing on the development of molecules that mimic the beneficial effects of CR without reducing food intake. Some of these candidate molecules include plant-derived functional chemicals (phytochemicals), synthetic small molecules, and endocrine molecules such as adipokines. Several studies have already shown that this research field may yield novel drugs for the treatment of age-related diseases such as diabetes. In this article, we describe the target pathways, candidate molecules, and strategies to develop CR mimetics.

KW - Biosensing

KW - Calorie restriction

KW - Cancer

KW - Drug discovery

KW - Metabolism

KW - Neurodegeneration

UR - http://www.scopus.com/inward/record.url?scp=78650027487&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=78650027487&partnerID=8YFLogxK

U2 - 10.2174/138920210793360934

DO - 10.2174/138920210793360934

M3 - Article

C2 - 21629433

AN - SCOPUS:78650027487

VL - 11

SP - 562

EP - 567

JO - Current Genomics

JF - Current Genomics

SN - 1389-2029

IS - 8

ER -